Internal Medicine, Gastroenterology · Houston, TX
NPI
1114920626
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
6400 Fannin St Ste 1400
Houston, TX, 77030
Phone (713) 500-6672
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
517 services
Medicare patients, 2024
264
Average age 71
Drug cost, 2024
$1.1M
672 prescriptions
Company payments, 2025
$90K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brooks D Cash was code 99214 (office e&m - established), 57 times for 46 patients. In total Brooks D Cash billed 517 services in 42 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 57 | 46 | $74.85 | $4,267 |
| 99223 Hospital E&M - Initial | Facility | 53 | 53 | $133.85 | $7,094 |
| 99215 Office E&M - Established | Office | 41 | 30 | $102.01 | $4,183 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 39 | 36 | $13.15 | $513 |
| 99233 Hospital E&M - Subsequent | Facility | 38 | 26 | $92.39 | $3,511 |
| 91010 Test - Miscellaneous | Office | 29 | 29 | $44.89 | $1,302 |
| 99204 Office E&M - New | Office | 23 | 23 | $97.65 | $2,246 |
| 43239 Upper GI Endoscopy | Office | 19 | 19 | $53.13 | $1,010 |
| 91010 Test - Miscellaneous | Facility | 18 | 18 | $45.30 | $815 |
| 45385 Colonoscopy - Lesion Removal | Office | 14 | 14 | $210.15 | $2,942 |
| 99213 Office E&M - Established | Office | 13 | 11 | $52.47 | $682 |
| 91038 Test - Miscellaneous | Office | 12 | 12 | $43.47 | $522 |
By year: 2022 $41K for 490 services; 2023 $41K for 472 services; 2024 $44K for 517 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brooks D Cash prescribed most often to Medicare patients was Motegrity (Prucalopride Succinate), with 66 prescriptions and refills. In total Brooks D Cash wrote 672 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Motegrity Prucalopride Succinate | 66 | 120 | 16 | $60K |
| Pantoprazole Sodium Generic | 51 | 149 | 23 | $1,260 |
| Esomeprazole Magnesium Generic | 32 | 78 | 11 | $1,247 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 31 | 43 | 15 | $1,050 |
| Xifaxan Rifaximin | 31 | 31 | 16 | $67K |
| Sucraid Sacrosidase | 30 | 30 | Under 11 | $397K |
| Ondansetron Odt Ondansetron | 27 | 27 | Under 11 | $1,077 |
| Omeprazole Generic | 24 | 68 | 12 | $279 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 23 | 23 | 22 | $1,517 |
| Trulance Plecanatide | 22 | 28 | Under 11 | $15K |
| Voquezna Vonoprazan Fumarate | 20 | 24 | Under 11 | $15K |
| Linzess Linaclotide | 20 | 39 | Under 11 | $20K |
| Cyproheptadine Hcl Generic | 17 | 37 | Under 11 | $412 |
| Octreotide Acetate Generic | 15 | 17 | Under 11 | $2,318 |
| Viberzi Eluxadoline | 15 | 22 | Under 11 | $35K |
Brand drugs: 285 claims; generic drugs: 387 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brooks D Cash $90K ($90K in general payments such as food, travel and fees) from 17 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $20K.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 21 | $20K |
| Alnylam Pharmaceuticals Inc. ALNY | 7 | $14K |
| Genzyme Corporation SNY | 6 | $12K |
| Ardelyx, Inc. ARDX | 10 | $12K |
| Napo Pharmaceuticals Inc | 1 | $6,892 |
| Azurity Pharmaceuticals, Inc. | 2 | $5,700 |
| Phathom Pharmaceuticals, Inc. PHAT | 6 | $5,650 |
| QOL Medical, LLC | 5 | $4,726 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $2,686 |
| Celltrion USA Inc. 068270.KS | 2 | $2,500 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.